Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure

NCT01860417 is registered in ClinicalTrials.gov with Red de Terapia Celular as lead sponsor.

NCT NCT01860417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01860417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure
Lead sponsor
Red de Terapia Celular
Phase
Phase 1/2
Overall status
Completed
Start date
June 21, 2013
Completion date
December 15, 2015
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, intervertebral disc disease, low back pain